Performance of Vitek MS v3.0 for Identification of Mycobacterium Species from Patient Samples by Use of Automated Liquid Medium Systems
- 1 August 2018
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 56 (8), e00219-18
- https://doi.org/10.1128/jcm.00219-18
Abstract
The accuracy and robustness of the Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) system was evaluated by identifying mycobacteria from automated liquid-medium systems using patient samples. This is the first report to demonstrate that proteins within the liquid medium, its supplements, and decontamination reagents for nonsterile patient samples do not generate misidentification or false-positive results by use of the Vitek MS v3.0 system. Prior to testing with patient samples, a seeded-culture study was conducted to challenge the accuracy of the Vitek MS system at identifying mycobacteria from liquid medium by mimicking a clinical workflow. Seventy-seven Mycobacterium strains representing 21 species, seeded in simulated sputum, were decontaminated, inoculated into BacT/Alert MP liquid culture medium, incubated until positivity, and identified using the Vitek MS system. A total of 383 liquid cultures were tested, of which 379 (99%) were identified correctly to the species/complex/group level, 4 (1%) gave a “no-identification” result, and no misidentifications were observed. Following the simulated-sputum study, a total of 73 smear-positive liquid-medium cultures detected using BD BBL MGIT and VersaTREK Myco liquid media were identified by the Vitek MS system. Sixty-four cultures (87.7%) were correctly identified to the species/complex/group level; 7 (9.6%) resulted in no identification; and 2 (2.7%) were misidentified at the species level. These results indicate that the Vitek MS v3.0 system is an accurate tool for routine diagnostics of Mycobacterium species isolated from liquid cultures.Keywords
Funding Information
- NIH/NCI Cancer Center Support Grant P30 (CA008748)
- bioMerieux Inc.
This publication has 29 references indexed in Scilit:
- Rapid Inactivation of Mycobacterium and Nocardia Species before Identification Using Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass SpectrometryJournal of Clinical Microbiology, 2014
- Comparison of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Mycobacteria Using Simplified Protein Extraction ProtocolsJournal of Clinical Microbiology, 2014
- Multicenter Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Gram-Positive Aerobic BacteriaJournal of Clinical Microbiology, 2013
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous MycobacteriaClinical Microbiology Reviews, 2012
- Rapid Identification of Mycobacterial Whole Cells in Solid and Liquid Culture Media by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryJournal of Clinical Microbiology, 2010
- Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a reviewClinical Microbiology & Infection, 2010
- Commercial DNA Probes for Mycobacteria Incorrectly Identify a Number of Less Frequently Encountered SpeciesJournal of Clinical Microbiology, 2010
- Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003Thorax, 2007
- rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing MycobacteriaJournal of Clinical Microbiology, 2003
- Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNANucleic Acids Research, 1989